These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

423 related items for PubMed ID: 15196638

  • 1. Drug carrier systems based on water-soluble cationic beta-cyclodextrin polymers.
    Li J, Xiao H, Li J, Zhong Y.
    Int J Pharm; 2004 Jul 08; 278(2):329-42. PubMed ID: 15196638
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Analysis of triclosan inclusion complexes with β-cyclodextrin and its water-soluble polymeric derivative.
    Jug M, Kosalec I, Maestrelli F, Mura P.
    J Pharm Biomed Anal; 2011 Apr 05; 54(5):1030-9. PubMed ID: 21215544
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Influence of cyclodextrin complexation on piroxicam gel formulations.
    Jug M, Bećirević-Laćan M, Kwokal A, Cetina-Cizmek B.
    Acta Pharm; 2005 Sep 05; 55(3):223-36. PubMed ID: 16375834
    [Abstract] [Full Text] [Related]

  • 8. Preparation and characterization of simvastatin/hydroxypropyl-beta-cyclodextrin inclusion complex using supercritical antisolvent (SAS) process.
    Jun SW, Kim MS, Kim JS, Park HJ, Lee S, Woo JS, Hwang SJ.
    Eur J Pharm Biopharm; 2007 Jun 05; 66(3):413-21. PubMed ID: 17240129
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Effect of pH and water-soluble polymers on the aqueous solubility of nimesulide in the absence and presence of beta-cyclodextrin derivatives.
    Alexanian C, Papademou H, Vertzoni M, Archontaki H, Valsami G.
    J Pharm Pharmacol; 2008 Nov 05; 60(11):1433-9. PubMed ID: 18957163
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Physicochemical, in silico and in vivo evaluation of a danazol-beta-cyclodextrin complex.
    Jadhav GS, Vavia PR.
    Int J Pharm; 2008 Mar 20; 352(1-2):5-16. PubMed ID: 18023545
    [Abstract] [Full Text] [Related]

  • 16. Characterization of physicochemical properties of naproxen systems with amorphous beta-cyclodextrin-epichlorohydrin polymers.
    Mura P, Faucci MT, Maestrelli F, Furlanetto S, Pinzauti S.
    J Pharm Biomed Anal; 2002 Aug 01; 29(6):1015-24. PubMed ID: 12110386
    [Abstract] [Full Text] [Related]

  • 17. Nuclear magnetic resonance investigations of the inclusion complexation of gliclazide with beta-cyclodextrin.
    Moyano JR, Arias-Blanco MJ, Gines JM, Rabasco AM, Pérez-Martínez JI, Mor M, Giordano F.
    J Pharm Sci; 1997 Jan 01; 86(1):72-5. PubMed ID: 9002462
    [Abstract] [Full Text] [Related]

  • 18. Study of solubility of isoproturon by its complexation with beta-cyclodextrin.
    Manolikar MK, Sawant MR.
    Chemosphere; 2003 Jun 01; 51(8):811-6. PubMed ID: 12668040
    [Abstract] [Full Text] [Related]

  • 19. Dissolution properties and characterization of halofantrine-2-hydroxypropyl-beta-cyclodextrin binary systems.
    Onyeji CO, Omoruyi SI, Oladimeji FA.
    Pharmazie; 2007 Nov 01; 62(11):858-63. PubMed ID: 18065103
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.